Item Type | Name |
Academic Article
|
Letter: Should ineffective agents be used in combination chemotherapy?
|
Academic Article
|
Cutaneous T-cell lymphoma: a review.
|
Academic Article
|
Herpes zoster and small cell bronchogenic carcinoma.
|
Academic Article
|
Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancer.
|
Academic Article
|
Abdominal computed tomography in small cell lung cancer: assessment of extent of disease and response to therapy.
|
Academic Article
|
The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypes.
|
Academic Article
|
Small cell lung cancer 1973-1983: early progress and recent obstacles.
|
Academic Article
|
Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy.
|
Academic Article
|
Possible enhancement of vincristine neuropathy by VP-16.
|
Academic Article
|
Combination chemotherapy of hepatocellular carcinoma with doxorubicin and streptozotocin.
|
Academic Article
|
Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapy.
|
Academic Article
|
A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer: a University of Colorado Cancer Center study.
|
Academic Article
|
New treatment agents for advanced small cell and non-small cell lung cancer.
|
Academic Article
|
Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the S?zary syndrome).
|
Academic Article
|
Combined modality therapy in small cell lung cancer.
|
Academic Article
|
Secondary screening system for preclinical testing of human lung cancer therapies.
|
Academic Article
|
The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
|
Academic Article
|
Controversies in the nonsurgical treatment of stage III non-small cell lung cancer.
|
Academic Article
|
The role of routine chest radiotherapy in small-cell lung cancer. An issue of timing and stage.
|
Academic Article
|
Antimicrobial therapy in patients allergic to penicillin.
|
Academic Article
|
Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer.
|
Academic Article
|
Interferon in the treatment of cutaneous T-cell lymphoma.
|
Academic Article
|
Smoking abstinence and small cell lung cancer survival. An association.
|
Academic Article
|
Influence of histologic subtype of small cell carcinoma of the lung on clinical presentation, response to therapy, and survival.
|
Academic Article
|
Bleomycin, methotrexate, and streptozotocin in epidermoid carcinoma of the lung: an active drug combination with major nonhematologic toxicity.
|
Academic Article
|
Experience of the National Cancer Institute (USA) in the treatment and biology of small cell lung cancer.
|
Academic Article
|
Small-cell carcinoma of lung: reinduction therapy after late relapse.
|
Academic Article
|
Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemia.
|
Academic Article
|
T-cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute: history and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL) and adult T-cell leukemia-lymphomas (ATLL).
|
Academic Article
|
Novel bradykinin antagonist dimers for the treatment of human lung cancers.
|
Academic Article
|
Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness.
|
Academic Article
|
Combination paclitaxel and platinum in the treatment of lung cancer: US experience.
|
Academic Article
|
Future directions in therapeutic approaches for small cell lung cancer.
|
Academic Article
|
Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoides.
|
Academic Article
|
5th I.A.S.L.C. Lung Tumor Biology Workshop, August 13-17, 1996, Ermatingen, Switzerland.
|
Academic Article
|
Treatment of cutaneous T-cell lymphoma.
|
Academic Article
|
The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer.
|
Academic Article
|
Induction paclitaxel/carboplatin in early stage non-small cell lung cancer. Bimodality Lung Oncology Team.
|
Academic Article
|
A phase I study of daily carboplatin and simultaneous accelerated, hyperfractionated chest irradiation in patients with regionally inoperable non-small cell lung cancer.
|
Academic Article
|
The emerging role of gemcitabine in lung cancer.
|
Academic Article
|
Systemic investigational therapies as adjuvants to surgery in patients with operable lung cancer.
|
Academic Article
|
Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer?
|
Academic Article
|
A Southwest Oncology Group Phase I study of the sequential combination of recombinant interferon-gamma and recombinant interleukin-2 in patients with cancer.
|
Academic Article
|
Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study.
|
Academic Article
|
Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team.
|
Academic Article
|
New therapeutic strategies for lung cancer: biology and molecular biology come of age.
|
Academic Article
|
New combinations in the treatment of lung cancer: a time for optimism.
|
Academic Article
|
HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer.
|
Academic Article
|
A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma.
|
Academic Article
|
Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial.
|
Academic Article
|
Current therapy of small cell lung cancer.
|
Academic Article
|
Fifth I.A.S.L.C. Lung Tumor Biology Workshop, August 13-17, 1996, Ermatingen, Switzerland.
|
Academic Article
|
ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer.
|
Academic Article
|
Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
|
Academic Article
|
Pemetrexed as a single agent in the therapy of advanced lung cancer.
|
Academic Article
|
Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors).
|
Academic Article
|
Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer.
|
Academic Article
|
Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions.
|
Academic Article
|
Single-dose murine monoclonal antibody ricin A chain immunotoxin in the treatment of metastatic melanoma: a phase I trial.
|
Academic Article
|
An update on North American randomized studies in non-small cell lung cancer.
|
Academic Article
|
Treatment of subacute bacterial endocarditis.
|
Academic Article
|
A comparison of therapeutic efficacy between a triple sulfonamide mixture and gantrisin in urinary tract infections.
|
Academic Article
|
Chemotherapy for elderly patients with advanced non-small-cell lung cancer.
|
Academic Article
|
LABORATORY AND CLINICAL STUDIES WITH CLOXACILLIN.
|
Academic Article
|
MANAGEMENT AND ENDOCARDITIS WITH SYNTHETIC PENICILLINS.
|
Academic Article
|
Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments.
|
Academic Article
|
State of the art therapy of mycosis fungoides and S?zary syndrome.
|
Academic Article
|
Understanding the mechanisms of action of EGFR inhibitors in NSCLC: what we know and what we do not know.
|
Academic Article
|
Treatment of pneumococcal pneumonia with erythromycin and carbomycin (magnamycin).
|
Academic Article
|
Treatment of pylephlebitis secondary to acute appendicitis.
|
Academic Article
|
The use of the rabbit eye as a tissue to study tuberculosis. IV. Effect of therapy with streptomycin-isoniazid and with growth hormone (STH) upon the course of the infection.
|
Academic Article
|
The future of cyclooxygenase-2 inhibitors and other inhibitors of the eicosanoid signal pathway in the prevention and therapy of lung cancer.
|
Academic Article
|
The potential role of proteasome inhibitors in the treatment of lung cancer.
|
Academic Article
|
Absorption and clinical use of penicillin preparations given in large oral doses; a cooperative study utilizing discontinuous therapy.
|
Academic Article
|
A phase I and pharmacokinetic study of exisulind and docetaxel in patients with advanced solid tumors.
|
Academic Article
|
Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective.
|
Academic Article
|
Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
|
Academic Article
|
Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer.
|
Academic Article
|
Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancer.
|
Academic Article
|
Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study.
|
Academic Article
|
Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma.
|
Academic Article
|
Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy.
|
Academic Article
|
Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines.
|
Academic Article
|
Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer.
|
Academic Article
|
Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer.
|
Academic Article
|
Selecting lung cancer patients for treatment with epidermal growth factor receptor tyrosine kinase inhibitors by immunohistochemistry and fluorescence in situ hybridization--why, when, and how?
|
Academic Article
|
Operation for stage IIIa small cell lung cancer?
|
Academic Article
|
Can a single pill replace doublet chemotherapy in first-line therapy of advanced non-small cell lung cancer?
|
Academic Article
|
From radiotherapy to Targeted therapy: 20 years in the management of non-small-cell lung cancer.
|
Academic Article
|
Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study.
|
Academic Article
|
Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.
|
Academic Article
|
Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the S?zary syndrome.
|
Academic Article
|
Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma.
|
Academic Article
|
Summary report 7th Annual Targeted Therapies of the Treatment of Lung Cancer.
|
Academic Article
|
Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy.
|
Academic Article
|
Streptomycin in the treatment of human tuberculosis.
|
Academic Article
|
EGFR and HER2 genomic gain in recurrent non-small cell lung cancer after surgery: impact on outcome to treatment with gefitinib and association with EGFR and KRAS mutations in a Japanese cohort.
|
Academic Article
|
Novel therapies for non-small-cell lung cancer: a 2008 update.
|
Academic Article
|
Innovative and future approaches to small cell lung cancer treatment.
|
Academic Article
|
New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer.
|
Academic Article
|
Optimal therapy for elderly patients with early stage non-small cell lung cancer.
|
Academic Article
|
Treatment of hepatic insufficiency.
|
Academic Article
|
Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression.
|
Academic Article
|
The expanding role of cisplatin in the treatment of non-small-cell lung cancer.
|
Academic Article
|
A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides.
|
Academic Article
|
Oral iloprost improves endobronchial dysplasia in former smokers.
|
Academic Article
|
The therapeutic role of interferons and monoclonal antibodies in cutaneous T-cell lymphomas.
|
Academic Article
|
Preclinical and clinical studies of docetaxel and exisulind in the treatment of human lung cancer.
|
Academic Article
|
Results of therapeutic cranial irradiation in small cell lung cancer.
|
Academic Article
|
A trial of combination chemotherapy followed by hormonal therapy for previously untreated metastatic carcinoma of the prostate.
|
Academic Article
|
Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-up.
|
Academic Article
|
Cyclophosphamide, doxorubicin, and etoposide as first-line therapy in the treatment of small-cell lung cancer.
|
Academic Article
|
The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas.
|
Academic Article
|
Alpha interferon treatment of low-grade B-cell non-Hodgkin's lymphomas, cutaneous T-cell lymphomas, and chronic lymphocytic leukemia.
|
Academic Article
|
New targeted therapies for lung cancer: expectations and reality.
|
Academic Article
|
Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
|
Academic Article
|
Status of kanamycin in therapy of infections.
|
Academic Article
|
Role of radiation therapy in small cell anaplastic carcinoma of the lung.
|
Academic Article
|
Small cell lung cancer: radionuclide bone scans for assessment of tumor extent and response.
|
Academic Article
|
Small cell carcinoma presenting as an extrapulmonary neoplasm: sites of origin and response to chemotherapy.
|
Academic Article
|
Effective treatment of hormonally-unresponsive metastatic carcinoma of the prostate with adriamycin and cyclophosphamide: methods of documenting tumor response and progression.
|
Academic Article
|
Present trends in the treatment of the pneumonias.
|
Academic Article
|
Advances in the use of antibacterial substances.
|
Academic Article
|
Rational therapy for cutaneous T-cell lymphomas in the 1990s. Fact or fancy?
|
Academic Article
|
Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group.
|
Academic Article
|
Treatment of pneumococcal pneumonia with a new penicillin: clinical observations in 25 patients.
|
Academic Article
|
Irinotecan and platinums in the treatment of non small-cell lung cancer.
|
Academic Article
|
Combinations of three chemotherapeutic agents and two chemotherapeutic agents plus a targeted biologic agent in the treatment of advanced non small-cell lung cancer.
|
Academic Article
|
Future directions in clinical research for lung cancer.
|
Academic Article
|
Cutaneous T cell lymphomas.
|
Academic Article
|
Novel agents in the treatment of lung cancer: conference summary statement.
|
Academic Article
|
European School of Oncology. First Euro-American Forum on Lung Cancer Treatment.
|
Academic Article
|
Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomas.
|
Academic Article
|
Small cell lung cancer: etiology, biology, clinical features, staging, and treatment.
|
Academic Article
|
Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group study.
|
Academic Article
|
Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
|
Academic Article
|
The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
|
Academic Article
|
New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.
|
Academic Article
|
Cancer and acquired immunodeficiency syndrome wasting syndromes: current and future therapies.
|
Academic Article
|
Immune therapy for lung cancer: are we getting closer?
|
Academic Article
|
Triplet combination chemotherapy and targeted therapy regimens.
|
Academic Article
|
Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer.
|
Academic Article
|
Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy.
|
Academic Article
|
[State-of-the art treatment of locally advanced and metastatic non-small cell lung cancer].
|
Academic Article
|
Serial fiberoptic bronchoscopy during chemotherapy for small cell carcinoma of the lung: early detection of patients at high risk of relapse.
|
Academic Article
|
Expression of target molecules in lung cancer: challenge for a new treatment paradigm.
|
Academic Article
|
Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
|
Academic Article
|
Response to thoracic radiotherapy in patients with small cell carcinoma of the lung after failure of combination chemotherapy.
|
Academic Article
|
Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival.
|
Academic Article
|
Ongoing and future trials of biologic therapies in lung cancer.
|
Academic Article
|
Pyoarthritis: its treatment and the role of adrenal steroids in its pathogenesis.
|
Academic Article
|
TREATMENT OF ACUTE BRONCHOPULMONARY INFECTIONS.
|
Academic Article
|
Treatment of pneumococcal meningitis with large doses of penicillin; a series of twenty consecutive cases.
|
Academic Article
|
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.
|
Academic Article
|
Unusual chemosensitivity of advanced bronchioalveolar carcinoma after gefitinib response and progression: a case report.
|
Academic Article
|
Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients.
|
Academic Article
|
A phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer.
|
Academic Article
|
Single-institution experience with pemetrexed and bevacizumab as salvage therapy in advanced non-small-cell lung cancer.
|
Academic Article
|
Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.
|
Academic Article
|
Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents.
|
Academic Article
|
First-generation epidermal growth factor receptor inhibitors in non-small cell lung cancer: clinical impact of the epidermal growth factor receptor fluorescence in situ hybridization assay.
|
Academic Article
|
Anti-growth factor therapy for lung cancer.
|
Academic Article
|
Summary of selected presentations from the 8th annual targeted therapy in lung cancer symposium.
|
Academic Article
|
Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.
|
Academic Article
|
The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer.
|
Academic Article
|
Docetaxel and exisulind in previously treated non-small cell lung cancer (NSCLC) patients: a multicenter, phase II clinical trial.
|
Academic Article
|
Interferon therapy for lymphoproliferative disorders.
|
Academic Article
|
Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial.
|
Academic Article
|
Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Conclusion.
|
Academic Article
|
Diseases desperate grown.
|
Academic Article
|
Molecularly targeted therapy: when to stop and when to continue?
|
Academic Article
|
Review of therapeutic trials of carboplatin in lung cancer.
|
Academic Article
|
The tissue is the issue: personalized medicine for non-small cell lung cancer.
|
Academic Article
|
Early-stage NSCLC: the role of radiotherapy and systemic therapy.
|
Academic Article
|
Treatment of infections with penicillin given orally.
|
Academic Article
|
A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancer.
|
Academic Article
|
Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer.
|
Academic Article
|
Worldwide overview of the current status of lung cancer diagnosis and treatment.
|
Academic Article
|
Biologically targeted therapies plus chemotherapy plus radiotherapy in stage III non-small-cell lung cancer: a case of the Icarus syndrome?
|
Academic Article
|
Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer.
|
Academic Article
|
Lung cancer in 2013: state of the art therapy for metastatic disease.
|
Academic Article
|
The role of radiation therapy in the treatment of small cell lung cancer.
|
Academic Article
|
Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer.
|
Academic Article
|
Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer.
|
Academic Article
|
Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial.
|
Academic Article
|
Interferon therapy of non-Hodgkin's lymphoma.
|
Academic Article
|
Alpha-interferon treatment of cutaneous T cell lymphoma and chronic lymphocytic leukemia.
|
Academic Article
|
Therapeutic options in advanced cutaneous T cell lymphomas: a role for interferon alfa-2a (Roferon-A).
|
Concept
|
Ultraviolet Therapy
|
Concept
|
Neoadjuvant Therapy
|
Concept
|
Genetic Therapy
|
Concept
|
Drug Therapy, Combination
|
Concept
|
Treatment Outcome
|
Concept
|
PUVA Therapy
|
Concept
|
Salvage Therapy
|
Concept
|
Combined Modality Therapy
|
Concept
|
Drug Therapy
|
Concept
|
Biological Therapy
|
Concept
|
Treatment Failure
|
Academic Article
|
Progress in research on screening and genetics in lung cancer.
|
Academic Article
|
Recent clinical advances in lung cancer management.
|
Academic Article
|
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.
|
Academic Article
|
Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer.
|
Academic Article
|
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.
|
Academic Article
|
Personalized one-two punches for lung cancer.
|
Academic Article
|
Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations.
|
Academic Article
|
New and emerging targeted treatments in advanced non-small-cell lung cancer.
|
Academic Article
|
Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment.
|
Academic Article
|
Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal?from the Bench.
|
Academic Article
|
Karnofsky Award 2016: A Lung Cancer Journey, 1973 to 2016.
|
Academic Article
|
The role of irinotecan combined with Cisplatin or Carboplatin in the treatment of advanced non-small-cell lung cancer.
|
Academic Article
|
Current therapeutic approaches in lung cancer.
|
Academic Article
|
Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancer.
|
Grant
|
7TH WORLD CONFERENCE ON LUNG CANCER
|
Grant
|
Lung Cancer Mutation Analysis
|
Grant
|
SPORE in Lung Cancer
|
Grant
|
COLORADO BLUEPRINT--WOMEN/MINORITIES CANCER CARE TRIAL
|
Grant
|
UC4 AP4 Cancer Therapy Center
|
Academic Article
|
Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung.
|
Academic Article
|
Small-cell lung cancer: what we know, what we need to know and the path forward.
|
Academic Article
|
The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2).
|
Academic Article
|
Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer.
|
Academic Article
|
Resistance Mechanisms to Targeted Therapies in ROS1+ and ALK+ Non-small Cell Lung Cancer.
|
Academic Article
|
Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.
|
Academic Article
|
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.
|
Academic Article
|
Systemic Therapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancers.
|
Academic Article
|
Broad-Based Molecular Testing for Lung Cancer: Precisely the Time for Precision.
|
Academic Article
|
Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer.
|
Academic Article
|
Advancements in Small-cell Lung Cancer: The Changing Landscape Following IMpower-133.
|
Academic Article
|
New Developments in Neoadjuvant Therapy for Lung Cancer.
|
Academic Article
|
Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience.
|
Concept
|
Molecular Targeted Therapy
|
Academic Article
|
Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer.
|
Academic Article
|
IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy.
|
Academic Article
|
Optimal Therapy for Advanced Non-Small Cell Lung Cancer Without Driver Alterations.
|
Academic Article
|
Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non-small cell lung cancer.
|
Academic Article
|
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.
|
Academic Article
|
Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer.
|
Academic Article
|
CNS Downstaging: An Emerging Treatment Paradigm for Extensive Brain Metastases in Oncogene-Addicted Lung Cancer.
|
Academic Article
|
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions.
|
Academic Article
|
International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy.
|
Academic Article
|
Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study.
|